It is a very strong set of regulations, and we need to remember that old saying that “Hard cases make bad law.” There will be extreme cases where the mismatch between the price that is asked and the value that is delivered is very large.
We have to ask ourselves, do we want to pay massively over value? Do we want to sacrifice a lot more of other Canadians' health to avoid these reductions in revenues?
You only get that if actually the expected value, how it impacts on patients' health, is completely out of kilter with the price that the manufacturers are asking to be paid, yet if you are out kilter on your ask, you will see a very large reduction. That's not necessarily a bad thing, because I don't think any of us want taxpayers' money to be paid for low-value technologies, which is what will be the case in that circumstance.